Page last updated: 2024-08-23

etoposide and concanavalin a

etoposide has been researched along with concanavalin a in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duguet, M; Jaxel, C; Mirambeau, G; Panijel, J; Portemer, C; Taudou, G1
Eibl, MM; Kaider, A; Krainer, M; Kratzik, C; Wilfing, A; Wiltschke, C; Wolf, HM; Zielinski, CC1
Osann, KE; Slater, LM; Stupecky, M; Sweet, P1
Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M1
Demirbilek, M; Demirbilek, ME; Denkbaş, EB; Erdal, E; Kavaz, D; Saglam, N; Sam, M1

Other Studies

5 other study(ies) available for etoposide and concanavalin a

ArticleYear
Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes.
    Biochemistry, 1988, Jan-12, Volume: 27, Issue:1

    Topics: Animals; Camptothecin; Concanavalin A; DNA; DNA Replication; DNA Topoisomerases, Type II; Etoposide; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred C57BL; Novobiocin; Phenylmethylsulfonyl Fluoride; Spleen; Sulfones; Topoisomerase II Inhibitors

1988
Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy.
    Urology, 2000, Volume: 55, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Concanavalin A; Etoposide; Germinoma; Humans; Immunity, Cellular; Lectins; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Receptors, Interleukin-2; Testicular Neoplasms

2000
Enhancement of leukemia rejection by mice successfully treated for L1210 leukemia due to low dose compared to high dose VP-16.
    Leukemia research, 2002, Volume: 26, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Concanavalin A; Cyclosporine; Cyclosporins; Drug Screening Assays, Antitumor; Etoposide; Graft Rejection; Immunosuppressive Agents; Leukemia L1210; Lymphocyte Activation; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Phytohemagglutinins

2002
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
    Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:8

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid

2007
Preparation and characterization of magnetically responsive bacterial polyester based nanospheres for cancer therapy.
    Journal of biomedical nanotechnology, 2012, Volume: 8, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Concanavalin A; Cupriavidus necator; Etoposide; HeLa Cells; Humans; Magnetite Nanoparticles; Materials Testing; Nanocapsules; Nanospheres; Polyhydroxyalkanoates; Prohibitins

2012
chemdatabank.com